Tilray Net Profit Margin 2017-2020 | TLRY

Tilray net profit margin from 2017 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
Tilray Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2020-06-30 $0.20B $-0.52B -261.00%
2020-03-31 $0.20B $-0.48B -242.86%
2019-12-31 $0.17B $-0.32B -192.22%
2019-09-30 $0.14B $-0.13B -97.06%
2019-06-30 $0.10B $-0.12B -121.05%
2019-03-31 $0.06B $-0.09B -155.93%
2018-12-31 $0.04B $-0.07B -154.55%
2018-09-30 $0.03B $-0.04B -121.21%
2018-06-30 $0.03B $-0.02B -82.14%
2018-03-31 $0.02B $-0.01B -52.17%
2017-12-31 $0.02B $-0.01B -40.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.759B $0.167B
Tilray, Inc. is a pharmaceutical company. It develops cannabis based medicines, drugs, drops and oil products. Tilray, Inc. is based in NANAIMO, Canada.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.589B 43.56
Takeda Pharmaceutical (TAK) Japan $50.286B 9.38
Astellas Pharma (ALPMY) Japan $25.898B 0.00
Eisai (ESALY) Japan $23.767B 20.08
UCB SA (UCBJF) Belgium $20.005B 0.00
Merck (MKGAF) Germany $19.897B 26.09
Ono Pharmaceutical (OPHLF) Japan $15.938B 28.18
Catalent (CTLT) United States $14.706B 47.80
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.683B 24.18
Grifols, S.A (GRFS) Spain $11.592B 14.17
Neurocrine Biosciences (NBIX) United States $9.225B 35.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.221B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.076B 13.36
IPSEN SA ADR (IPSEY) France $7.465B 0.00
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $6.545B 41.46
Orion OYJ (ORINY) Finland $6.272B 21.76
Arrowhead Pharmaceuticals (ARWR) United States $5.942B 0.00
United Therapeutics (UTHR) United States $5.788B 12.32
Evotec AG (EVTCY) Germany $4.416B 142.16
Sage Therapeutics (SAGE) United States $3.841B 0.00
PTC Therapeutics (PTCT) United States $3.649B 0.00
FibroGen (FGEN) United States $3.525B 0.00
ChemoCentryx (CCXI) United States $3.412B 0.00
Hypermarcas (HYPMY) Brazil $3.142B 11.56
Nektar Therapeutics (NKTR) United States $2.900B 0.00
Pacira BioSciences (PCRX) United States $2.270B 50.11
Taro Pharmaceutical Industries (TARO) Israel $2.251B 11.49
Xencor (XNCR) United States $2.243B 0.00
Revolution Medicines (RVMD) United States $2.079B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.026B 0.00
Corcept Therapeutics (CORT) United States $1.983B 18.25
Cronos Group (CRON) Canada $1.949B 0.00
USANA Health Sciences (USNA) United States $1.653B 14.56
Ironwood Pharmaceuticals (IRWD) United States $1.539B 10.69
Heron Therapeutics (HRTX) United States $1.457B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.307B 12.46
Trillium Therapeutics (TRIL) Canada $1.261B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.232B 0.00
Zogenix (ZGNX) United States $1.182B 0.00
Karyopharm Therapeutics (KPTI) United States $1.146B 0.00
Endo (ENDP) Ireland $1.087B 1.61
Indivior (INVVY) United States $1.031B 12.78
CLINIGEN GP (CLIGF) United Kingdom $1.028B 0.00
Translate Bio (TBIO) United States $1.005B 0.00
ImmunoGen (IMGN) United States $0.988B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.882B 549.00
Esperion Therapeutics (ESPR) United States $0.873B 0.00
Vectura Group (VEGPF) United Kingdom $0.795B 0.00
Ocular Therapeutix (OCUL) United States $0.677B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.659B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.647B 32.29
Radius Health (RDUS) United States $0.640B 0.00
Collegium Pharmaceutical (COLL) United States $0.623B 0.00
Flexion Therapeutics (FLXN) United States $0.589B 0.00
VAXART, INC (VXRT) United States $0.580B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.569B 0.00
Siga Technologies (SIGA) United States $0.511B 54.50
Spectrum Pharmaceuticals (SPPI) United States $0.510B 0.00
Aerie Pharmaceuticals (AERI) United States $0.502B 0.00
Molecular Templates (MTEM) United States $0.474B 0.00
Ardelyx (ARDX) United States $0.466B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.426B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.410B 0.00
Organogenesis Holdings (ORGO) United States $0.385B 0.00
Harpoon Therapeutics (HARP) United States $0.380B 0.00
Altimmune (ALT) United States $0.376B 0.00
TherapeuticsMD (TXMD) United States $0.359B 0.00
DURECT (DRRX) United States $0.353B 0.00
Profound Medical (PROF) Canada $0.341B 0.00
Redhill Biopharma (RDHL) Israel $0.327B 0.00
Akebia Therapeutics (AKBA) United States $0.325B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.322B 7.97
Concert Pharmaceuticals (CNCE) United States $0.319B 0.00
KalVista Pharmaceuticals (KALV) United States $0.308B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.302B 0.00
MEI Pharma (MEIP) United States $0.299B 0.00
Jounce Therapeutics (JNCE) United States $0.297B 14.05
Innate Pharma SA (IPHYF) France $0.291B 0.00
Menlo Therapeutics (VYNE) United States $0.288B 0.00
Rafael Holdings (RFL) United States $0.276B 0.00
Lannett Co Inc (LCI) United States $0.259B 6.02
Calithera Biosciences (CALA) United States $0.253B 0.00
CASI Pharmaceuticals (CASI) United States $0.239B 0.00
CTI BioPharma (CTIC) United States $0.233B 0.00
Xeris Pharmaceuticals (XERS) United States $0.228B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.223B 0.00
IMV INC (IMV) Canada $0.217B 0.00
Nature's Sunshine Products (NATR) United States $0.213B 20.98
Oasmia Pharmaceutical AB (OASMY) Sweden $0.211B 0.00
Aduro Biotech (KDNY) United States $0.193B 0.00
Nivalis Therapeutics (ALPN) United States $0.183B 0.00
Otonomy (OTIC) United States $0.177B 0.00
Aquestive Therapeutics (AQST) United States $0.175B 0.00
Heat Biologics (HTBX) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.170B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.163B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.162B 0.00
OptiNose (OPTN) United States $0.154B 0.00
Champions Oncology (CSBR) United States $0.112B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
MediWound (MDWD) Israel $0.091B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Lipocine (LPCN) United States $0.083B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.080B 0.00
Hemispherx BioPharma (AIM) United States $0.079B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.077B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.069B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.066B 0.00
Biomerica (BMRA) United States $0.066B 0.00
ElectroCore (ECOR) United States $0.065B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.065B 0.00
Novan (NOVN) United States $0.065B 0.00
AgeX Therapeutics (AGE) United States $0.065B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.065B 0.00
Infinity Pharmaceuticals (INFI) United States $0.065B 0.00
Addex Therapeutics (ADXN) Switzerland $0.060B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.059B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
Onconova Therapeutics (ONTX) United States $0.048B 0.00
India Globalization Capital (IGC) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 27.36
Forward Pharma (FWP) Denmark $0.044B 0.00
Recro Pharma (REPH) United States $0.040B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Mannatechorporated (MTEX) United States $0.034B 8.67
GTx (ONCT) United States $0.031B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.030B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.030B 0.00
IsoRay (ISR) United States $0.029B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.027B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.026B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Cyanotech (CYAN) United States $0.018B 26.59
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
Vical (BBI) United States $0.017B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sundial Growers (SNDL) Canada $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Hancock Jaffe Laboratories (HJLI) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.013B 0.00
Bio-Path Holdings (BPTH) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Iterum Therapeutics (ITRM) Ireland $0.010B 0.00
China SXT Pharmaceuticals (SXTC) China $0.010B 0.00
Shineco (TYHT) China $0.008B 0.00
JanOne (JAN) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00